Herpes Simplex Virus 1 & 2, IgM

Herpes simplex virus (HSV), known as herpes, causes infections related to the skin. Herpes is highly contagious and can be spread through sexual contact or skin-to-skin contact with an infected person. The infection lasts a lifetime. Most HSV infections are asymptomatic or unrecognized, but symptoms of herpes include painful blisters or ulcers that can recur over time. Herpes is not curable, however, it can be well managed with medications. 

HSV-1 and HSV-2 are two strains of the herpes virus that can cause infections, usually related to the skin. HSV-1 is primarily associated with oral herpes, causing cold sores or blisters around the mouth and lips. It can spread through skin-to-skin contact such as kissing. Furthermore, HSV-2 causes genital herpes, resulting in painful sores and blisters in the genital area. It can spread through sexual contact and is considered a sexually transmitted disease. Therefore, the Herpes Simplex Virus 1 & 2, IgM testing plays a vital role in identifying individuals with HSV 1 & 2 infections, including asymptomatic (those who do not show any symptoms) individuals who may unknowingly transmit the virus to others. 

Your doctor may recommend the Herpes Simplex Virus 1 & 2, IgM test when you are experiencing symptoms suggestive of herpes infection. Symptoms may include painful, recurring blisters or ulcers, painful urination, unusual discharge from the urethra and vagina, fever, body aches, sore throat, and swollen lymph nodes. This test specifically detects the presence of IgM antibodies in the blood, which are produced in response to an active or recent herpes infection. Also, the Herpes Simplex Virus 1 & 2, IgM test is used to confirm the presence of the virus during the early stages of infection or for individuals experiencing their first outbreak.

No special preparation is needed before undergoing the Herpes Simplex Virus 1 & 2, IgM test. Talk to your doctor about your specific test results. Narrate your complete medical history and symptoms to help them correlate your clinical and laboratory findings and formulate your treatment plan. It is important to communicate with your partners about the infection to ensure informed decisions regarding risk reduction. Negative results do not rule out the possibility of infection. Retesting is recommended after 8-14 days.